Year 2015 (49)

Edition nr. 9


www.verkouden.nl

This website extensively discusses the favourable data obtained in clinical research into Bisolviral as a therapy for the common cold. But what is the significance of a reduction in viral counts if this does not reduce the level or duration of th ...

Read article


Febuxostat and agranulocytosis

An article in Gebu 2015; 49: 46-47 concluded that although febuxostat effectively lowers serum uric acid levels, there was insufficient evidence for its efficacy in terms of clinical outcome measures and safety, and insufficient evidence to intro ...

Read article


Ten myths about the pharmaceutical industry: myth 8

8. We need many drugs of the same type, as patient response is highly variable. There are quite a few categories of drugs with many representatives on the market. Most of these can be regarded as ‘me too’ drugs, that is, drugs that are virtually ...

Read article


Are phthalates in medical devices harmful?

It has been strongly recommended not to use phthalates, especially DEHP, in medical devices, as there is a risk of the agent being released into the body. This recommendation came into effect immediately for pregnant women and children below the ...

Read article


NHG Guideline on ADHD in Children

The Guideline on ‘ADHD in Children’ published by the Dutch College of General Practitioners (NHG) offers GPs leads for answering questions about ‘hyperactive’ children. It elaborately discusses the conditions for establishing the diagnosis of ADH ...

Read article


Olodaterol, Striverdi® Respimat® (Boehringer Ingelheim)

Inhalation fluid 2.5 µg Maintenance therapy for COPD Olodaterol is the fourth long-acting β2-sympathicomimetic to be marketed as a monotherapy for COPD. In four double-blind randomised trials, olodaterol achieved a statistically significant incre ...

Read article


Dulaglutide, Trulicity® (Eli Lilly)

Subcutaneous injection fluid with 0.75 and 1.5 mg per 0.5 mL Treatment of type 2 diabetes mellitus A search of the literature reveals that no well-designed randomised double-blind trials into the efficacy of dulaglutide relative to existing drugs ...

Read article